Breaking News Instant updates and real-time market news.

BGNE

BeiGene

$31.79

0.11 (0.35%)

09:47
10/07/16
10/07
09:47
10/07/16
09:47

BeiGene says BGB-3111 'well-tolerated, highly active' in WM

BeiGene presented updated clinical data from an ongoing Phase I study of BTK inhibitor BGB-3111 in patients with Waldenstrom's macroglobulinemia at the 9th International Workshop on Waldenstrom's Macroglobulinemia and Symposium on Advances in Multiple Myeloma in Amsterdam, The Netherlands. The preliminary clinical data demonstrate that BGB-3111 is well-tolerated and highly active in WM, with an overall response rate of 92%, including major response in 83% and very good partial response in 33%, at a median follow-up time of 8.0 months. "The updated data continue to show that BGB-3111 is well-tolerated and highly active in Waldenstrom's macroglobulinemia. The ability to achieve complete and sustained BTK inhibition in both circulating and nodal lymphocytes appears to have translated into very good response frequency and quality, as reflected by the VGPR rate of 33%," commented Constantine Tam, MD, Disease Group Lead for Low Grade Lymphoma and Chronic Lymphocytic Leukemia at Peter MacCallum Cancer Centre, Australia, coordinating principal investigator of the study.

  • 07

    Oct

  • 06

    Nov

BGNE BeiGene
$31.79

0.11 (0.35%)

02/29/16
MSCO
02/29/16
INITIATION
Target $39
MSCO
Overweight
BeiGene initiated with an Overweight at Morgan Stanley
Target $39.
02/29/16
COWN
02/29/16
INITIATION
COWN
Outperform
BeiGene initiated with an Outperform at Cowen
Cowen initiated BeiGene with an Outperform rating as the company has proof-of-concept data on each of four clinical candidates and plans to monetize these assets on the global stage, in China, and via drug-drug combinations. Cowen expects BeiGene shares to appreciate as these candidates advance.
02/29/16
02/29/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. JPMorgan analyst Brian Ossenbeck initiated a cautious outlook for the North American truckload sector, saying he believes "tepid" freight demand and a lack of a boost to consumer spending from low gas prices will lead the first contraction in realized revenue per loaded mile since 2007. Ossenteck initiated Werner (WERN) with an Overweight rating due to expectations that its diversification will drive a re-rating of its shares. The analyst set a Neutral rating on Swift Transport (SWFT) and Ryder (R), and an Underweight rating on Heartland Express (HTLD) and Knight Transportation (KNX). 2. Editas Medicine (EDIT) initiated with an Outperform at Cowen and JMP Securities, and a Neutral at JPMorgan. Cowen cited the company's "world-class expertise" in CRISPR, which will enable the development of a broad pipeline. JPMorgan analyst Cory Kasimov added that the company's CRISPR gene editing platform has the potential to be a game changer, but that it has "limited value-inflecting news" likely to come in 2016. 3. BeiGene (BGNE) initiated with an Outperform at Cowen citing the proof-of-concept data on each of four clinical candidates and expects to monetize those assets on the global stage. The company was also initiated with an Overweight and a Buy at Morgan Stanley and Goldman, respectively. 4. Nielsen (NLSN) initiated with a Buy at Jefferies by analyst Ryan Cary, who said the company is well positioned to benefit from demand for cross-platform viewership measurement and greenfield in emerging markets provides protection against macro headwinds. 5. Square (SQ) initiated with a Sector Weight at Pacific Crest by analyst Josh Beck, who said his optimism is balanced by the market's high expectations for execution, the uncertain regulatory environment for SMB lending, and software initiatives. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, Reference Link
09/22/16
MAXM
09/22/16
INITIATION
Target $41
MAXM
Buy
BeiGene initiated with a Buy at Maxim
Maxim analyst Gabrielle Zhou initiated BeiGene with a Buy and a $41 price target. The analyst said BeiGene's BTK inhibitor, BGB-3111, is a de-risked, high-value asset, and based on its clinical profile and scarcity value, supports BeiGene's valuation and potential as the company works to bring the next BTK to market.

TODAY'S FREE FLY STORIES

CBS

CBS

$66.91

0.5 (0.75%)

09:03
04/27/17
04/27
09:03
04/27/17
09:03
Recommendations
CBS analyst commentary  »

CBS valuation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 04

    May

  • 08

    May

  • 15

    Jun

GRUB

GrubHub

$35.02

0.24 (0.69%)

09:03
04/27/17
04/27
09:03
04/27/17
09:03
Earnings
GrubHub sees FY17 revenue $632M-$662M, consensus $644.39M »

Sees FY17 adjusted EBITDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 11

    May

  • 24

    May

  • 25

    May

BANC

Banc of California

$22.45

-0.15 (-0.66%)

09:03
04/27/17
04/27
09:03
04/27/17
09:03
Hot Stocks
Banc of California names Doug Bowers as CEO, effective May 8 »

Banc of California…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

ORRF

Orrstown Financial

$21.95

-0.45 (-2.01%)

09:03
04/27/17
04/27
09:03
04/27/17
09:03
Earnings
Orrstown Financial reports Q1 EPS 24c, consensus 20c »

Net interest income…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

GRUB

GrubHub

$35.02

0.24 (0.69%)

09:02
04/27/17
04/27
09:02
04/27/17
09:02
Earnings
GrubHub sees Q2 revenue $153M-$161M, consensus $157.95M »

Sees Q2 adjusted EBITDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 11

    May

  • 24

    May

  • 25

    May

GRUB

GrubHub

$35.02

0.24 (0.69%)

09:01
04/27/17
04/27
09:01
04/27/17
09:01
Earnings
GrubHub reports Q1 non-GAAP EPS 29c, consensus 24c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 11

    May

  • 24

    May

  • 25

    May

DISCA

Discovery

$29.39

0.1 (0.34%)

09:00
04/27/17
04/27
09:00
04/27/17
09:00
Periodicals
Discovery Asia partners with VS Media, Tabilabo, Variety says »

Discovery Networks Asia…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 08

    May

  • 18

    May

  • 31

    May

CNMD

CONMED

$48.13

0.93 (1.97%)

09:00
04/27/17
04/27
09:00
04/27/17
09:00
Recommendations
CONMED analyst commentary  »

CONMED price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 24

    May

UA

Under Armour

$18.14

0.17 (0.95%)

, UAA

Under Armour

$19.71

0.18 (0.92%)

09:00
04/27/17
04/27
09:00
04/27/17
09:00
Hot Stocks
Under Armour CFO sees Q4 to be strongest comparison of 2017 'by far' »

Under Armour CFO David…

UA

Under Armour

$18.14

0.17 (0.95%)

UAA

Under Armour

$19.71

0.18 (0.92%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 31

    May

09:00
04/27/17
04/27
09:00
04/27/17
09:00
General news
U.S. Advance trade deficit in goods widened slightly to -$64.8 B »

U.S. Advance trade…

SNCR

Synchronoss

$24.62

-0.02 (-0.08%)

09:00
04/27/17
04/27
09:00
04/27/17
09:00
Hot Stocks
Breaking Hot Stocks news story on Synchronoss »

Synchronoss trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

BGSF

BG Staffing

$15.15

-0.27 (-1.75%)

08:58
04/27/17
04/27
08:58
04/27/17
08:58
Earnings
BG Staffing reports Q1 EPS 15c, consensus 12c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 02

    May

TMO

Thermo Fisher

$168.01

9.2 (5.79%)

08:58
04/27/17
04/27
08:58
04/27/17
08:58
Recommendations
Thermo Fisher analyst commentary  »

Thermo Fisher price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    May

  • 06

    Jun

SNBC

Sun Bancorp

$25.70

-0.05 (-0.19%)

08:57
04/27/17
04/27
08:57
04/27/17
08:57
Earnings
Sun Bancorp reports Q1 EPS 7c, consensus 8c »

Reports Q1 NII $14.78M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 15

    May

UPS

UPS

$107.62

0.26 (0.24%)

08:57
04/27/17
04/27
08:57
04/27/17
08:57
Hot Stocks
UPS says sees margin improvement in 2017 »

Expects revenue to grow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 04

    May

  • 16

    May

  • 17

    May

  • 18

    May

  • 19

    May

  • 31

    May

RTN

Raytheon

$155.27

-0.74 (-0.47%)

08:56
04/27/17
04/27
08:56
04/27/17
08:56
Hot Stocks
Raytheon raises FY17 EPS view to $7.25-$7.40 from $7.20-$7.35, consensus $7.40 »

Raises FY17 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 31

    May

BA

Boeing

$181.71

-1.8 (-0.98%)

08:56
04/27/17
04/27
08:56
04/27/17
08:56
Recommendations
Boeing analyst commentary  »

Boeing price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

EXAS

Exact Sciences

$23.80

-1.09 (-4.38%)

08:56
04/27/17
04/27
08:56
04/27/17
08:56
Recommendations
Exact Sciences analyst commentary  »

Exact Sciences Q1 report…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 30

    May

  • 06

    Jun

AA

Alcoa

$36.45

-0.04 (-0.11%)

08:56
04/27/17
04/27
08:56
04/27/17
08:56
Syndicate
Alcoa 12.959M share Spot Secondary priced at $36.15 »

Citi and Credit Suisse…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

X

U.S. Steel

$22.78

-8.33 (-26.78%)

, NSC

Norfolk Southern

$117.82

1.04 (0.89%)

08:56
04/27/17
04/27
08:56
04/27/17
08:56
Options
Notable open interest changes for April 27th »

Wednesday's total…

X

U.S. Steel

$22.78

-8.33 (-26.78%)

NSC

Norfolk Southern

$117.82

1.04 (0.89%)

BAC

Bank of America

$23.89

-0.09 (-0.38%)

TWTR

Twitter

$15.82

1.16 (7.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

  • 11

    May

  • 31

    May

  • 06

    Jun

CTB

Cooper Tire

$43.40

0.05 (0.12%)

08:55
04/27/17
04/27
08:55
04/27/17
08:55
Technical Analysis
Cooper Tire drops sharply after earnings miss »

The stock was last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 18

    May

AAL

American Airlines

$46.40

-0.21 (-0.45%)

08:55
04/27/17
04/27
08:55
04/27/17
08:55
Hot Stocks
American Airlines sees positive revenue improvements in each quarter of 2017 »

American Airlines CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

UTHR

United Therapeutics

$119.99

-1.75 (-1.44%)

08:55
04/27/17
04/27
08:55
04/27/17
08:55
Recommendations
United Therapeutics analyst commentary  »

United Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

08:55
04/27/17
04/27
08:55
04/27/17
08:55
General news
The 14k initial claims pop to 257k »

The 14k initial claims…

08:55
04/27/17
04/27
08:55
04/27/17
08:55
Conference/Events
FDIC to hold a committee meeting »

The Committee on Economic…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.